Satellos Bioscience Inc.

TSX (CAD): Satellos Bioscience Inc. (MSCL)

Last Price

0.69

Today's Change

-0.12 (14.81%)

Day's Change

0.67 - 0.82

Trading Volume

110,193

Profile
MSCL

Exchange:  Toronto Stock Exchange Ventures Toronto Stock Exchange Ventures

Currency:  CAD CAD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Francis Gleeson B.B.A. M.B.A Mr. Francis Gleeson B.B.A. M.B.A

Full Time Employees:  0 0

IPO Date:  2008-01-07 2008-01-07

CIK: 

ISIN:  CA80401L3083 CA80401L3083

CUSIP: 

Beta:  1.21 1.21

Last Dividend:  0.00 0.00

Dcf Diff:  0.51 0.51

Dcf:  0.05 0.05

Description

Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

Address

65 Front Street East,
Toronto, ON M5E 1B5, CA

647 660 1780

http://satellos.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment